Event Title
Appropriateness of Statin Dose in High Risk Patients Post-PCI/CABG at Gwinnett Medical Center
Location
Georgia
Start Date
16-5-2017 1:00 PM
Description
Title: Appropriateness of Statin Dose in High Risk Patients Post-PCI/CABG at Gwinnett Medical Center
Primary investigator: Brandon Cunningham, PharmD
Mentor: Mary George, PharmD
Background: American College of Cardiology (ACC)/American Heart Association (AHA) guidelines for cholesterol and acute coronary syndrome (ACS) recommend high intensity statins for secondary prevention in high-risk coronary artery disease patients as they have been proven to significantly reduce recurrence of cardiovascular events. Analyses and reports have shown that major gaps still remain in implementation of high-intensity statins in these patients, despite strong guideline recommendations.
Based on these previous analyses and observations in prescribing practices, we decided to conduct this study to evaluate the gap in statin prescribing in post-percutaneous coronary intervention and coronary artery bypass graft patients at Gwinnett Medical Center.
Objectives:
Primary objective: Evaluate the appropriateness of the statin doses used in post-PCI/CABG patients based in ACC/AHA guideline recommendations
Secondary objective: Review discharge medication prescriptions for continuation of high intensity statin and compare admission statin to the discharge statin prescription
The findings of this review will be used to assist in modifying protocols that promote appropriate statin dosing for secondary prevention in high-risk coronary artery disease patients.
Methods:
Conduct a retrospective chart review utilizing CPOE and medical records to gather data on statin selection and doses from September 2016 to October 2016. Patient will be identified using ICD10 coding for coronary artery bypass graft (CABG) or percutaneous coronary intervention (PCI). Data to be reviewed will include patient demographics, statin allergies/intolerances, documented contraindications to statins, medication administration records, procedure performed (CABG or PCI), and discharge medication reconciliation records.
Embargo Period
6-26-2017
Appropriateness of Statin Dose in High Risk Patients Post-PCI/CABG at Gwinnett Medical Center
Georgia
Title: Appropriateness of Statin Dose in High Risk Patients Post-PCI/CABG at Gwinnett Medical Center
Primary investigator: Brandon Cunningham, PharmD
Mentor: Mary George, PharmD
Background: American College of Cardiology (ACC)/American Heart Association (AHA) guidelines for cholesterol and acute coronary syndrome (ACS) recommend high intensity statins for secondary prevention in high-risk coronary artery disease patients as they have been proven to significantly reduce recurrence of cardiovascular events. Analyses and reports have shown that major gaps still remain in implementation of high-intensity statins in these patients, despite strong guideline recommendations.
Based on these previous analyses and observations in prescribing practices, we decided to conduct this study to evaluate the gap in statin prescribing in post-percutaneous coronary intervention and coronary artery bypass graft patients at Gwinnett Medical Center.
Objectives:
Primary objective: Evaluate the appropriateness of the statin doses used in post-PCI/CABG patients based in ACC/AHA guideline recommendations
Secondary objective: Review discharge medication prescriptions for continuation of high intensity statin and compare admission statin to the discharge statin prescription
The findings of this review will be used to assist in modifying protocols that promote appropriate statin dosing for secondary prevention in high-risk coronary artery disease patients.
Methods:
Conduct a retrospective chart review utilizing CPOE and medical records to gather data on statin selection and doses from September 2016 to October 2016. Patient will be identified using ICD10 coding for coronary artery bypass graft (CABG) or percutaneous coronary intervention (PCI). Data to be reviewed will include patient demographics, statin allergies/intolerances, documented contraindications to statins, medication administration records, procedure performed (CABG or PCI), and discharge medication reconciliation records.
Comments
First-place winner of Excellence in Research-Residents/Fellows award